Abstract
A series of pyrazole analogues of curcumin were synthesized and investigated for in vitro and in silico antimicrobial activity. The structures of newly synthesized compounds were ascertained on the basis of their analytical and spectral profiles. The compounds were subjected to molecular docking studies for the inhibition of the enzyme glucosamine-6- phosphate synthase [GlcN-6-P]. The autodock program 4.2 was employed to perform automated molecular docking. The docking study was performed on two different active sites of the enzyme reside with the amino acid series Cys1, Arg73, Thr76, His77, Asn98, Gly99, Ile100 and Gly301, Thr302, Ser303, Ser347, Gln348, Ser349, Thr352, Lys485, Ala602, Val605 respectively. Among the thirteen molecules taken for docking studies, compounds cp10, cp11 and cp12 showed minimum docking energy and inhibition constant and may be considered as good inhibitor of GlcN-6-P synthase.
Keywords: Autodock 4.2, Active sites, Antimicrobial activity, GlcN-6-P synthase, Pyrazole, In silico.
Letters in Drug Design & Discovery
Title:Synthesis, Molecular Docking and In Vitro Antimicrobial Studies of Novel Pyrazole Analogues of Curcumin
Volume: 11 Issue: 4
Author(s): Dileep Kumar, Harish B. G., Mayank Gangwar, Manish Kumar, Dharmendra Kumar, Ragini Tilak, Gopal Nath, Ashok Kumar and Sushil Kumar Singh
Affiliation:
Keywords: Autodock 4.2, Active sites, Antimicrobial activity, GlcN-6-P synthase, Pyrazole, In silico.
Abstract: A series of pyrazole analogues of curcumin were synthesized and investigated for in vitro and in silico antimicrobial activity. The structures of newly synthesized compounds were ascertained on the basis of their analytical and spectral profiles. The compounds were subjected to molecular docking studies for the inhibition of the enzyme glucosamine-6- phosphate synthase [GlcN-6-P]. The autodock program 4.2 was employed to perform automated molecular docking. The docking study was performed on two different active sites of the enzyme reside with the amino acid series Cys1, Arg73, Thr76, His77, Asn98, Gly99, Ile100 and Gly301, Thr302, Ser303, Ser347, Gln348, Ser349, Thr352, Lys485, Ala602, Val605 respectively. Among the thirteen molecules taken for docking studies, compounds cp10, cp11 and cp12 showed minimum docking energy and inhibition constant and may be considered as good inhibitor of GlcN-6-P synthase.
Export Options
About this article
Cite this article as:
Kumar Dileep, G. B. Harish, Gangwar Mayank, Kumar Manish, Kumar Dharmendra, Tilak Ragini, Nath Gopal, Kumar Ashok and Singh Kumar Sushil, Synthesis, Molecular Docking and In Vitro Antimicrobial Studies of Novel Pyrazole Analogues of Curcumin, Letters in Drug Design & Discovery 2014; 11 (4) . https://dx.doi.org/10.2174/15701808113106660087
DOI https://dx.doi.org/10.2174/15701808113106660087 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bioactive Polyphenols from Grapes and Wine Emphasized with Resveratrol
Current Pharmaceutical Design TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases
Current Drug Targets Editorial from Guest Editor [Hot Topic:Vitamin D and Respiratory Health (Guest Editor: Adrian R. Martineau)]
Current Respiratory Medicine Reviews COVID-19 Effects on Geriatric Population and Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccines in the Prevention and Treatment of COVID-19
Current Medicinal Chemistry Gene Therapy for Lysosomal Storage Diseases: Progress, Challenges and Future Prospects
Current Pharmaceutical Design Cardiac Tissue Engineering
Recent Patents on Regenerative Medicine The Immunological Side-Effects of Sedative Agents in the Intensive Care Unit
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Current Therapeutic Approaches in Inflammatory Bowel Disease
Current Pharmaceutical Design Health Benefits of Honey: Implications for Treating Cardiovascular Diseases
Current Nutrition & Food Science Editorial [Hot topic: New Developments in the Treatment and Prevention of Vascular Disease - Part 1 (Executive Editors: N. Katsiki, V.G. Athyros and D.P. Mikhailidis)]
Current Pharmaceutical Design Predicting Toxicity: Biomarkers and the Value of the Patient's Opinion
Current Pharmaceutical Design Drug Therapy for Behavioral and Psychological Symptoms of Dementia
Current Neuropharmacology The Association of Lipodystrophy and Oxidative Stress Biomarkers in HIV-Infected Men
Current HIV Research Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design Lecithin (Phosphatidylcholine): Healthy Dietary Supplement or Dangerous Toxin?
The Natural Products Journal Pediatric Catatonia: Updating An Old Syndrome in Young People
Current Psychiatry Reviews Nongenomic Actions of Thyroid Hormones: From Basic Research to Clinical Applications. An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Congenital Parenchymal Lesions of the Lung
Current Respiratory Medicine Reviews Prematurely Aged Children: Molecular Alterations Leading to Hutchinson-Gilford Progeria and Werner Syndromes
Current Aging Science 30 Years Lost in Anesthesia Theory
Cardiovascular & Hematological Agents in Medicinal Chemistry